The latest quarterly R&D expense is $207.00 Million with a QoQ Growth of -35.91%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-27).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-27): $207.00M.
$207.00M
$207.00 Million
Q2 FY2026 · 2026-06-27
-35.91%
vs. $323.00M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-27 | $207.00M | -35.91% | -26.60% |
| Q1 FY2026Period end 2026-03-28 | $323.00M | +11.38% | +17.45% |
| Q4 FY2025Period end 2025-12-27 | $290.00M | -4.61% | +3.20% |
| Q3 FY2025Period end 2025-09-27 | $304.00M | +7.80% | +0.33% |
| Q2 FY2025Period end 2025-06-28 | $282.00M | +2.55% | +10.16% |
| Q1 FY2025Period end 2025-03-29 | $275.00M | -2.14% | +13.17% |
| Q4 FY2024Period end 2024-12-31 | $281.00M | -7.26% | +24.89% |
| Q3 FY2024Period end 2024-09-28 | $303.00M | +18.36% | +38.99% |
| Q2 FY2024Period end 2024-06-29 | $256.00M | +5.35% | +21.33% |
| Q1 FY2024Period end 2024-03-30 | $243.00M | +8.00% | +3.40% |
| Q4 FY2023Period end 2023-12-31 | $225.00M | +3.21% | +0.45% |
| Q3 FY2023Period end 2023-09-30 | $218.00M | +3.32% | +5.83% |
| Q2 FY2023Period end 2023-07-01 | $211.00M | -10.21% | +17.88% |
| Q1 FY2023Period end 2023-04-01 | $235.00M | +4.91% | +30.56% |
| Q4 FY2022Period end 2022-12-31 | $224.00M | +8.74% | +45.45% |
| Q3 FY2022Period end 2022-10-01 | $206.00M | +15.08% | +56.06% |
| Q2 FY2022Period end 2022-06-30 | $179.00M | -0.56% | +39.84% |
| Q1 FY2022Period end 2022-03-31 | $180.00M | +16.88% | +38.46% |
| Q4 FY2021Period end 2021-12-31 | $154.00M | +16.67% | N/A |
| Q3 FY2021Period end 2021-09-30 | $132.00M | +3.13% | N/A |
| Q2 FY2021Period end 2021-06-26 | $128.00M | -1.54% | N/A |
| Q1 FY2021Period end 2021-03-27 | $130.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
